DUANE ROTH AUDITORIUM
SANFORD CONSORTIUM FOR
REGENERATIVE MEDICINE

Join us for an exciting symposium exploring research at the intersection of maternal-fetal health, neurodevelopment, and placental science. This event will bring together experts from diverse disciplines to discuss the latest findings on how prenatal and perinatal risk factors impact fetal brain development and strategies for neuroprotection.

SATURDAY MAY 31 • 9AM TO 5PM

POSTER SESSION 4PM-5PM
TRAINEES CAN PRESENT A PREVIOUSLY-PRESENTED-POSTER

**REGISTRATION INFORMATION COMING SOON**

Meet the Keynote Speakers

Serena Banu Gumusoglu, M.Sc., Ph.D.

"Neurodevelopmental risk after exposure to a complex pregnancy: offering a translational perspective"

     
     Dr. Gumusoglu is an Assistant Professor of Obstetrics and Gynecology and Psychiatry at the University of Iowa Carver College of Medicine. Her translational research program focuses on the molecular mechanisms by which obstetric disease increases risk for psychiatric disease in pregnant people and in the next generation. This work is funded by prestigious awards from the Burroughs Wellcome Fund, the Brain and Behavior Research Foundation, and others. Originally from Portland, OR, Banu earned her BS from the George Washington University MSc in Developmental Neuroscience and Psychopathology through the join Yale-University College London Bridge Program. Banu completed her PhD in Neuroscience with Dr. Hanna Stevens at the University of Iowa, and a postdoctoral fellowship in Reproductive Science and High-Risk Obstetrics with Dr. Mark Santillan at the Carver College of Medicine. She is passionate about mentorship of diverse trainees, collaboration across fields, and champions the importance of prenatal life in shaping lifespan health.

Terrie Inder, M.D.

"Protecting the Immature Brain"

    Dr. Inder is a native New Zealander who has worked in the United States for two decades. She is a dual trained newborn medicine physician and child neurologist with her research focus in the newborn brain. She also undertakes clinical service within the neonatal intensive care unit. Dr. Inder's primary research is targeted at understanding the timing, mechanisms and impact of cerebral injury and altered cerebral development in infants at high risk for adverse neurodevelopmental outcome, including the prematurely-born infant, the sick term-born infant, and the infant with congenital heart disease. Her aim in her investigations is to investigate means of accurate, early diagnosis of brain injury as well as developing treatments and preventive strategies to reduce subsequent disabilities.